Off the wire
• 1st China-Belgium innovation dialogue convenes in Brussels  • Spain's Fernandez wins men's short program at figure skating worlds  • Majority of French voters want Socialist candidate Hamon to quit race: survey  • CPC issues document to strengthen theoretical study  • China, Serbia vow to solidify friendship, cooperation  • Javelin world champ Yego to compete in Finland  • UNICEF decries rise in malnutrition, disease among Somali children  • Chinese construction giant begins works on rail line rehabilitation in Serbia  • Roundup: S. African opposition seek to impeach President Zuma  • Roundup: Indonesian club Persib attracts former English Premier League stars  
You are here: 　 Home

Swedish prostate cancer test to be introduced in Europe

Xinhua, March 30, 2017 Adjust font size:

A new test to improve prostate cancer diagnosis is to be tried out in clinics in Germany, the Netherlands, and Belgium, according to a press release from Sweden's Karolinska Institutet on Thursday.

Stockholm3 is a blood test that is thought by researchers to be more effective in detecting aggressive prostate cancer, while at the same time reducing the number of unnecessary biopsies by 50 percent compared to the current clinical practice. It was introduced to the Swedish health care system in December 2016.

The Stockholm3 test is based on research conducted at Karolinska Institutet. In a clinal study, researchers tested 60,000 men between the ages of 50 and 70 years old. The results have been published in numerous scientific journals.

EIT Health, supported by the EU body European Innovation and Technology (EIT), is providing the financing for the clinical validation of the Stockholm3 test. Endit